Savers Value Village GC exercises options, sells 2,300 shares via 10b5-1 plan

Rhea-AI Filing Summary

Richard A. Medway, General Counsel of Savers Value Village, Inc. (SVV), executed option-related transactions on 09/05/2025. He exercised 2,300 options at an exercise price of $1.41 per share and simultaneously sold the 2,300 resulting shares under a preexisting 10b5-1 plan at a weighted average price of approximately $13.00 per share. After these transactions, the reporting person beneficially owns 399,456 shares underlying outstanding options. The filing notes the exercised options were part of a 2019 grant that fully vested March 28, 2024, and that roughly 20% of outstanding options are time-based while 80% are performance-based with partial IPO-based vesting.

Positive

• Large remaining option position: the reporting person retains 399,456 shares underlying options, preserving alignment with shareholder value creation.
• Use of 10b5-1 plan: the sale of 2,300 shares was executed under a preexisting 10b5-1 plan adopted March 10, 2025, indicating a preplanned disposition.

Negative

• Immediate monetization: 2,300 shares were sold at a weighted average of ~$13.00, representing realized cash proceeds and reduced direct share ownership to 0 for the reported class.
• Concentration of performance-based awards: ~80% of outstanding options are performance-based, meaning intrinsic value depends on future metric achievement and may not vest.

Insights

Securities Analyst

TL;DR: Insider exercised vested options and sold a small lot under a 10b5-1 plan; substantial option holdings remain.

The filing documents a routine exercise-and-sale on 09/05/2025: 2,300 options were exercised at $1.41 and the resulting shares were sold via a 10b5-1 plan at a weighted average of ~$13.00. This monetized a portion of vested compensation while leaving significant option exposure of 399,456 shares. The 2019 grant structure (time- and performance-based tranches) and IPO-triggered vesting for some awards are clearly disclosed, indicating alignment of remaining upside with future performance metrics.

Corporate Governance Expert

TL;DR: Transactions appear compliant and preplanned, reducing optics of opportunistic trading but retain material incentive alignment.

The report clarifies the sale was executed pursuant to a 10b5-1 plan adopted March 10, 2025, which provides an affirmative defense for planned insider sales. The form discloses vesting schedules and the mix of time- versus performance-based options, supporting governance transparency. No amendments or unusual disclosures are present in the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Medway Richard A.

(Last) (First) (Middle)

C/O SAVERS VALUE VILLAGE, INC.

11400 SE 6TH, SUITE 125

(Street)

BELLEVUE WA 98004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Savers Value Village, Inc. [ SVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/05/2025		M		2,300	A	$1.41	2,300	D
Common Stock	09/05/2025		S(1)		2,300	D	$13(2)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Purchase)(3)	$1.41	09/05/2025		M			2,300	(4)	06/12/2029	Common Stock	2,300	$1.41	399,456(5)	D

Explanation of Responses:

1. The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 10, 2025.

2. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.98 to $13.00. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

3. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.

4. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024.

5. Approximately 20% represents time-based options which vested in substantially equal annual installments over five years starting March 28, 2020, and approximately 80% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.

Remarks:

	/s/ Richard Medway	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Richard A. Medway (SVV) do on 09/05/2025?

He exercised 2,300 options at $1.41 per share and sold the resulting 2,300 shares under a 10b5-1 plan for a weighted average of ~$13.00 per share.

How many shares does the reporting person beneficially own after the transactions?

The filing shows beneficial ownership of 399,456 shares underlying options following the reported transactions.

Was the sale discretionary or preplanned?

The sale was executed pursuant to a 10b5-1 plan adopted on March 10, 2025, indicating a preplanned disposition.

What are the vesting characteristics of the reported options?

The 2019 grant vested in substantially equal annual installments beginning March 28, 2020, fully vested for the referenced grant on March 28, 2024; approximately 20% are time-based and 80% are performance-based with partial IPO-triggered vesting.

At what price were the sold shares executed?

The shares were sold in a range from $12.98 to $13.00, with a reported weighted average of approximately $13.00 per share.